A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms
Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the efficacy and toxicity including quality of life of
two types of low-dose interferon alpha compounds (PegIntron and Pegasys) with hydroxyurea
(Hydrea), and to investigate the occurence of neutralizing antibodies against recombinant
interferon.